Your browser doesn't support javascript.
loading
Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma.
Aya, Francisco; Gaba, Lydia; Victoria, Iván; Fernández-Martínez, Aranzazu; Tosca, Mónica; Prat, Aleix; Arance, Ana.
Afiliación
  • Aya F; Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain.
  • Gaba L; Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain.
  • Victoria I; Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain.
  • Fernández-Martínez A; Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain.
  • Tosca M; Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain.
  • Prat A; Targeted Therapeutics & Translational Genomics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain.
  • Arance A; Medical Oncology Department, Hospital Clinic Barcelona, Villaroel 170, 08036 Barcelona, Spain.
Future Oncol ; 12(23): 2683-2688, 2016 Dec.
Article en En | MEDLINE | ID: mdl-27581765
Asunto(s)
Palabras clave
Buscar en Google
Imprimir
XML
PubMed Links

Base de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Antígeno CTLA-4 / Melanoma / Anticuerpos Monoclonales / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2016 Tipo del documento: Article País de afiliación: España
Buscar en Google
Imprimir
XML
PubMed Links

Base de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Antígeno CTLA-4 / Melanoma / Anticuerpos Monoclonales / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2016 Tipo del documento: Article País de afiliación: España